Raurich J M, Rialp G, Ibáñez J, Ayestarán I, Llompart-Pou J A, Togores B
Intensive Care Unit, Son Dureta University Hospital, Palma de Mallorca, Illes Balears, Spain.
Anaesth Intensive Care. 2009 Sep;37(5):726-32. doi: 10.1177/0310057X0903700507.
We evaluated the hypercapnia response test as a weaning outcome predictor from mechanical ventilation in patients with chronic obstructive pulmonary disease (COPD). We studied 44 COPD intubated patients considered ready for a weaning trial. The hypercapnia test was based on the modified method of re-inhalation of expired air Through the hypercapnic test we calculated the ratio of the change in minute volume (V(E)) to the change in PaCO2 (deltaV(E)/deltaPaCO2), the change in airway occlusion pressure at 0.1 second of inspiration (P0.1) to change in PaCO2 (deltaP0.1/deltaPACO2), the ratio of the change in P0.1 to baseline PaCO2 (deltaP0.1/PaCO2) and the ratio of the change in V(E) to baseline PaCO2 (deltaV(E)/PaCO2). Nineteen patients were successfully weaned and 25 patients failed. No differences in baseline clinical characteristics were found between the two groups. Weaning failure COPD patients had lower deltaP0.1/deltaPaCO2 (0.19 +/- 0.11 and 0.34 +/- 0.20 cm H2O/mmHg respectively, P = 0.006) and lower deltaV(E)/deltaPaCO2 (0.21 +/- 0.15 and 0.40 +/- 0.22 l/min/mmHg respectively, P = 0.002) than successfully weaned patients. The area under the receiver operating characteristic curve to discriminate weaning outcome was for the baseline PaCO2 0.81 (95% confidence interval: 0.66 to 0.91), hypercapnic PaCO2 0.76 (0.61 to 0.88), hypercapnic drive response 0.74 (0.59 to 0.86), hypercapnic ventilatory response 0.76 (0.60 to 0.87), deltaP0.1/PaCO2 0.76 (0.60 to 0.87) and for the deltaV(E)/PaCO2 0.81 (0.67 to 0.91). COPD patients with weaning failure have a significantly more blunted response to the hypercapnia response test than weaning success patients. This test could be useful to predict weaning failure patients if the combined values of the hypercapnic drive and hypercapnic ventilatory response were below the threshold values.
我们评估了高碳酸血症反应试验作为慢性阻塞性肺疾病(COPD)患者机械通气撤机结果预测指标的价值。我们研究了44例被认为准备好进行撤机试验的COPD插管患者。高碳酸血症试验基于改良的呼出气体再吸入方法。通过高碳酸血症试验,我们计算了分钟通气量变化(V(E))与动脉血二氧化碳分压变化(deltaV(E)/deltaPaCO2)的比值、吸气0.1秒时气道闭塞压变化(P0.1)与动脉血二氧化碳分压变化(deltaP0.1/deltaPACO2)的比值、P0.1变化与基线动脉血二氧化碳分压的比值(deltaP0.1/PaCO2)以及V(E)变化与基线动脉血二氧化碳分压的比值(deltaV(E)/PaCO2)。19例患者成功撤机,25例患者撤机失败。两组患者的基线临床特征无差异。撤机失败的COPD患者的deltaP0.1/deltaPaCO2(分别为0.19±0.11和0.34±0.20 cm H2O/mmHg,P = 0.006)和deltaV(E)/deltaPaCO2(分别为0.21±0.15和0.40±0.22 l/min/mmHg,P = 0.002)低于成功撤机的患者。用于区分撤机结果的受试者工作特征曲线下面积,对于基线动脉血二氧化碳分压为0.81(95%置信区间:0.66至0.91),高碳酸血症动脉血二氧化碳分压为0.76(0.61至0.88),高碳酸血症驱动反应为0.74(0.59至0.86),高碳酸血症通气反应为0.76(0.60至0.87),deltaP0.1/PaCO2为0.76(0.60至0.87),deltaV(E)/PaCO2为0.81(0.67至0.91)。撤机失败的COPD患者对高碳酸血症反应试验的反应明显比撤机成功的患者更迟钝。如果高碳酸血症驱动和高碳酸血症通气反应的综合值低于阈值,该试验可能有助于预测撤机失败的患者。